52
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Cerebrovascular Involvement in Liposome—Induced Cardiopulmonary Distress in Pigs

, Ph.D. , M.D., , , , , & show all
Pages 3-14 | Published online: 09 Dec 2008

References

  • Anonymous. (1997). Rheoence phalograph. (a) Identification. In: Code of Federal Regulations. Washington, D.C.: U.S. Government Printing Office, Vol. 8. Title 21, Parts 800 to 1299. Revised as of April 1, 1997.
  • Anonymous. (2002). Doxorubicin. www.MayoClinic.com Drug Information>USP Drug Guide- Drug Information.htm, 3/3/2002.
  • (1980). Moskalenko, Y. E., ed. Biophysical Aspects of Cerebral Circulation. Oxford: Pergamon.
  • Bodo, M., Racz, J., Ilias, L., Pasztor, A., Vajda, J., Weinstein, G. B., Pasztor, E., Moskalenko, Y. E. (1986). Rheoencephalographic changes during increased intracranial pressure. In: Krieglstein, J., ed. Pharmacology of Cerebral Ischemia. Amsterdam: Elsevier, pp. 265–269.
  • Bodo, M., Pearce, F. J., Thuroczy, G., Braisted, J., Montgomery, L. D., Kubinyi, G., Forcino, D., Baranyi, L., Heilig, J., Nagy, I., Morrissette, C., Lee, J. (2001). Electrical impedance validations: in vitro and in vivo studies. In: Grimmes, S., Martinsen, O. G., Bruvoll, H., eds. Biophysical Aspects of Cerebral Circulation. Oslo: Unipob Vorlag, June 17–21, pp. 325–329.
  • Bodo, M., Pearce, F. J., Montgomery, L. D., Rosenthal, M., Kubinyi, G., Thuroczy, G., Braisted, J., Forcino, D., Morrissette, C., Nagy, I. (2003). Measurement of brain electrical impedance: animal studies in rheoencephalography. Aviat. Space Environ. Med. 74:506–511. [PUBMED], [INFOTRIEVE], [CSA]
  • Bodo, M., Pearce, F. J., Armonda, R. A. (2004). Cerebral blood flow changes: rat studies in rheoencephalography.Physiol Meas 25:1371–1384.
  • Bodo, M., Pearce, F. J., Baranyi, L., Armonda, R. A. (2005). Changes in the intracranial rheoencephalogram at lower limit of cerebral blood flow autoregulation.Physiol. Meas. 26:S1–S17.
  • Chillon, J. M., Baumbach, G. L. (2002) Autoregulation: arterial and intracranial pressure. In: Edvinsson, L., Krause, D. N., eds. Cerebral Blood Flow and Metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, pp. 395–412.
  • Dirnagl, U., Lindauer, U., Them, A., Schreiber, S., Pfister, H. W., Koedel, U., Reszka, R., Freyer, D., Villringer, A. (1995). Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo.J Cereb Blood Flow Metab 15:929–940.
  • Ekstrom-Jodal, B., Haggendal, E., Larsson, L. E. (1982). Cerebral blood flow and oxygen uptake in endotoxic shock: an experimental study in dogs.Acta Anaesthesiol. Scand. 26:163–170.
  • Ganong, W. F. (2001). Review of Medical Physiology. 20th ed. New York: Lange.
  • Gabizon, A., Muggia, F. M. (1998). Initial clinical evaluation of pegylated liposomal doxorubicin in solid tumors. In: Woodle, M. C, ed. Long-Circulating Liposomes: Old Drugs, New Therapeutics. Austin: Landes Bioscience, pp. 155–174.
  • Geddes, L. A., Baker, L. E. (1989). Principles of Applied Biomedical Instrumentation. 3rd ed. New York: Wiley.
  • Hadjiev, D. (1968). A new method for quantitative evaluation of cerebral blood flow by rheoencephalography.Brain Res 8:213–215.
  • (1970). In: Markovich, S. E. ed. International Conference on Bioelectrical Impedance. Vol. 170. Annals of New York Academy of Sciences, pp.407–836. Art. 2.
  • Jacquy, J., Dekoninck, W. J., Piraux, A., Calay, R., Bacq, J., Levy, D., Noel, G. (1974). Cerebral blood flow and quantitative rheoencephalography.Electroencephalogr. Clin. Neurophysiol. 37:507–511.
  • Jenkner, F. L. (1986). Clinical Rheonecephalography: a Non-Invasive Method for Automatic Evaluation of Cerebral Hemodynamics. Vienna: Ertldruck.
  • Johansson, B. B. (1992). Experimental models of altering the blood-brain barrier.Prog. Brain. Res. 91:171–175.
  • Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., Kotamraju, S. (2002). Doxorubicin-induced apoptosis: implications in cardiotoxicity.Mol. Cell. Biochem. 234–235:119–124.
  • Kapin, M. A., Law, W. R., Raymond, R. M., Ferguson, J. L. (1986). The cerebral circulatory response during canine anaphylactic shock.Circ. Shock 120:115–125.
  • Kontos, H. A., Wei, E. P., Navari, R. M., Levasseur, J. E., Rosenblum, W. I., Patterson, J. L. Jr. (1978). Responses of cerebral arteries and arterioles to acute hypotension and hypertension.Am. J. Physiol. Heart Circ. Physiol. 34:H371–H383.
  • Krause, R. S. (1999). Anaphylaxis. http://emedicine.com/emerg/topics25.htm 12/24/99.
  • Krause, D. N. (2002). Endothelial regulation. In: Edvinsson, L., Krause, D. N., eds. Cerebral Blood Flow and Metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, pp. 107–118.
  • Lang, E. W., Chesnut, R. M. (2000). A bedside method for investigating the integrity and critical thresholds of cerebral perfusion pressure autoregulation in severe traumatic brain injury patients.Br. J. Neurosurg. 14:117–126.
  • Laverman, P., Boerman, O. C., Oyen, W. JG., Corstens, F. H. M., Storm, G. (2001). In vivo applications of PEG-liposomes: unexpected observations.Crit. Rev. Ther. Drug. Carr. Syst. 18:551–566.
  • Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., Park, J. W. (2003). Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR-and EGFRvIII-overexpressing tumor cells.Cancer Res. 15(63–12):3154–3161.
  • Marceau, F., Lundberg, C., Hugli, T. E. (1987). Effects of anaphylatoxins on circulation.Immunopharmacol 14:67–84.
  • McLean, J. W., Fox, E. A., Baluk, P., Bolton, P. B., Haskell, A., Pearlman, R., Thurston, G., Umemoto, E. Y., McDonald, D. M. (1997). Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice.Am. J. Physiol. 273:H387–H404.
  • Miller, C. F., Breslow, M. J., Shapiro, R. M., Traystman, R. J. (1987). Role of hypotension in decreasing cerebral blood flow in porcine endotoxemia.Am. J. Physiol. 253(4 Pt 2):H956–H964.
  • Moibenko, A. A., Grabovskii, L. A., Kotsiuruba, V. N., Bulakh, V. N., Tumanovskaia, L. V., Azarov, V. I., Butovich, I. A. (1994). The mechanisms of the changes in coronary vascular resistance in anaphylactic shock.Fiziol. Z. Im. I. M. Sechenova 80:77–82.
  • Pacher, P., Liaudet, L., Bai, P., Mabley, J. G., Kaminski, P. M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M. S., Groves, J. T., Szabo, C. (2003). Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.Circulation 107:896–904.
  • Panerai, R. B. (1998). Assessment of cerebral pressure autoregulation in humans—a review of measurement methods.Physiol. Meas. 19:305–338.
  • Parker, J. L., Emerson, T. E. Jr. (1977). Cerebral hemodynamics, vascular reactivity, and metabolism during canine endotoxin shock.Circ. Shock 4:4153.
  • Patterson, R. (1995). Bioelectric impedance measurement. In: Bronzino, J. D., ed. The Biomedical Engineering Handbook. Boca Raton: CRC press, pp. 1223–1230.
  • Popesko, P. (1979). Atlas of Topographical Anatomy of the Domestic Animals. Vol. 1. 3rd ed. Philadelphia: Saunders (Bratislava: Priroda).
  • Saito, A., Narasimhan, P., Hayashi, T., Okuno, S., Ferrand-Drake, M., Chan, P. H. (2004). Neuroprotective role of a proline-rich akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor.J. Neurosci. 24:1584–1593; doi:10.1523/JNEUROSCI.5209-03.
  • Shi, N., Pardridge, W. M. (2000). Non-invasive gene targeting to the brain.Proc. Natl. Acad. Sci. U. S. A. 97:7567–7572.
  • Speth, P. A., van Hoesel, Q. G., Haanen, C. (1988). Clinical pharmacokinetics of doxorubicin.Clin. Pharmacokinet. 15:15–31.
  • Strandgaard, S., Paulson, O. B. (1984). Cerebral autoregulation.Stroke 15:413–416.
  • Szebeni, J., Fontana, J. L., Wassef, N. M., Mongan, P. D., Morse, D. S., Dobbins, D. E., Stahl, G. L., Bunger, R., Alving, C. R. (1999). Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudo-allergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.Circulation 99:2302–2309.
  • Szebeni, J., Baranyi, L., Savay, S., Lutz, H. U., Jelezarova, E., Bunger, R., Alving, C. R. (2000). The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (Doxil®).J. Liposome. Res. 10:467–481.
  • Szebeni, J., Baranyi, L., Savay, S., Bodo, M., Morse, D. S., Basta, M., Bunger, R., Alving, C. R. (2000). Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.Am. J. Physiol. Heart. Circ. Physiol. 279:H1319–H1328.
  • Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., Muggia, F. M., Cohen, R., Barenholz, Y., Alving, C. R. (2002). The role of complement activation in hypersensitivity reactions to Doxil and hynic PEG liposomes: experimental and clinical studies.J. Liposome Res. 12:165–172.
  • Takada, G., Onodera, H., Tada, K. (1982). Delivery of fungal beta-galactosidase to rat brain by means of liposomes.Tohoku J. Exp. Med. 136:219–229.
  • Toyoda, K., Chu, Y., Heistad, D. D. (2003). Gene therapy for cerebral vascular disease: update.Br J Pharmacol. 139:1–9; doi: 10.1038/sj.bjp.0705217.
  • Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., Gabizon, A. (1995). Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.J. Clin. Oncol. 13:1777–1785.
  • Vainrub, A., Li, T. B., Fofanov, Y., Pettott, B. M. (2004). Theoretical considerations for the efficient design DNA arrays. In: Moore, J., Zouridakis, G., eds. Biomedical Technology and Devices Handbook. Boca Raton, FL: CRC Press, 14-1-14.
  • Vasquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S., Pritchard, K. A Jr, Kalyanaraman, B. (1997). Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin.Biochemistry 36(38):11293–11297.
  • Wang, S. C., Zhang, L., Hortobagyi, G. N., Hung, M. C. (2001). Targeting HER2: recent developments and future directions for breast cancer patients.Semin. Oncol. 28(6 suppl 18):21–29.
  • Westerlind, A., Larsson, L. E., Haggendal, J., Ekstrom-Jodal, B. (1991). Prevention of endotoxin-induced increase of cerebral oxygen consumption in dogs by propranolol pretreatment.Acta Anaesthesiol. Scand. 35:745–749.
  • Yee, S., Safra, T., Jeffers, S., Rosales, R., Teitelbaum, A. (1998). Prevention and Management of Doxil-Related Side Effects: Basic Strategies. ID Number: 281 http://www.asco.org/prof/me/html/98abstracts/asc/m_281.htm 3/4/2002.
  • Yoshimura, S., Morishita, R., Hayashi, K., Kokuzawa, J., Aoki, M., Matsumoto, K., Nakamura, T., Ogihara, T., Sakai, N., Kaneda, Y. (2002). Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model.Hypertension 39:1028–1034.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.